300347 泰格医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额317,7041,118,0851,097,0021,150,4381,357,501
投资活动产生之现金流量净额54,236491,557(4,739,122)(1,534,225)(2,789,366)
筹资活动产生之现金流量净额7,575(1,926,685)(1,702,410)(7,806)809,254
汇率变动对现金及现金等价物的影响(14,455)(8,842)(6,917)8,79326,934
现金及现金等价物净增加/(减少)365,060(325,885)(5,351,448)(382,800)(595,677)
期初现金及现金等价物余额1,722,6082,048,4947,399,9417,782,7418,378,418
期末现金及现金等价物余额2,087,6691,722,6082,048,4947,399,9417,782,741